Karo Pharma to Acquire E45 Brand from Reckitt
Dec. 24, 2021 – Karo Pharma Aktiebolag (“Karo”) has today entered into a put option agreement pursuant to which it may acquire the dermatology brand E45® from Reckitt for total consideration of GBP 200m (the “Transaction”). Subject to the execution of the put option by Reckitt, the acquisition of the E45® brand will be effected […]